Ashley Rosko

3.0k total citations
122 papers, 1.4k citations indexed

About

Ashley Rosko is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Ashley Rosko has authored 122 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Hematology, 47 papers in Oncology and 36 papers in Molecular Biology. Recurrent topics in Ashley Rosko's work include Multiple Myeloma Research and Treatments (52 papers), Frailty in Older Adults (27 papers) and Nutrition and Health in Aging (16 papers). Ashley Rosko is often cited by papers focused on Multiple Myeloma Research and Treatments (52 papers), Frailty in Older Adults (27 papers) and Nutrition and Health in Aging (16 papers). Ashley Rosko collaborates with scholars based in United States, Canada and Netherlands. Ashley Rosko's co-authors include Tanya M. Wildes, Don M. Benson, Yvonne A. Efebera, Craig C. Hofmeister, Andrew Artz, Sascha A. Tuchman, Shakira J. Grant, Jessica L. Krok‐Schoen, Ying Huang and Smith Giri and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Ashley Rosko

109 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ashley Rosko United States 20 713 584 461 230 166 122 1.4k
Charlotte Bradbury United Kingdom 15 194 0.3× 308 0.5× 451 1.0× 117 0.5× 41 0.2× 36 1.1k
Phillip Parente Australia 21 698 1.0× 87 0.1× 258 0.6× 178 0.8× 131 0.8× 82 1.5k
Phuong Nguyen United States 16 333 0.5× 184 0.3× 368 0.8× 14 0.1× 228 1.4× 57 1.3k
Camilla Qvortrup Denmark 23 1.1k 1.6× 66 0.1× 286 0.6× 70 0.3× 137 0.8× 86 1.6k
Kathleen Donohue United States 18 469 0.7× 237 0.4× 232 0.5× 14 0.1× 44 0.3× 36 1.1k
Elisabetta Todisco Italy 19 487 0.7× 410 0.7× 133 0.3× 41 0.2× 14 0.1× 56 1.1k
Sandra Kurtin United States 16 432 0.6× 284 0.5× 303 0.7× 13 0.1× 18 0.1× 78 884
Safi Shahda United States 24 852 1.2× 23 0.0× 559 1.2× 63 0.3× 212 1.3× 68 1.6k
Xiaobo Zhong United States 15 214 0.3× 265 0.5× 172 0.4× 16 0.1× 23 0.1× 59 706
Deborah Hurst United States 17 314 0.4× 1.0k 1.8× 373 0.8× 10 0.0× 79 0.5× 32 1.8k

Countries citing papers authored by Ashley Rosko

Since Specialization
Citations

This map shows the geographic impact of Ashley Rosko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashley Rosko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashley Rosko more than expected).

Fields of papers citing papers by Ashley Rosko

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ashley Rosko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashley Rosko. The network helps show where Ashley Rosko may publish in the future.

Co-authorship network of co-authors of Ashley Rosko

This figure shows the co-authorship network connecting the top 25 collaborators of Ashley Rosko. A scholar is included among the top collaborators of Ashley Rosko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ashley Rosko. Ashley Rosko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rosko, Ashley, Mohamed I. Elsaid, Jennifer A. Woyach, et al.. (2024). Determining the relationship of p16INK4a and additional molecular markers of aging with clinical frailty in hematologic malignancy. Journal of Cancer Survivorship. 18(4). 1168–1178. 3 indexed citations
2.
Mansour, Anthony G., Qiuhong Zhao, Francesca Cottini, et al.. (2024). Real World Predictors, Timing, and Outcomes of Autologous Stem Cell Transplantation in Patients with Multiple Myeloma. SHILAP Revista de lepidopterología. 5(4). 407–419.
3.
Ah, Diane Von, Erin Stevens, Ashley Rosko, et al.. (2024). Association between Cognitive Function and Physical Function, Frailty, and Quality of Life in Older Breast Cancer Survivors. Cancers. 16(15). 2718–2718. 2 indexed citations
4.
Chen, Pei, Naresh Bumma, Abdullah Khan, et al.. (2024). Cytomegalovirus Reactivation in Patients with Multiple Myeloma Treated with Teclistamab: Risk Factors and Clinical Impact. Blood. 144(Supplement 1). 4717–4717. 1 indexed citations
5.
Obeng‐Gyasi, Samilia, et al.. (2024). Practical Insights From Integrating Financial Hardship Screening at a Comprehensive Cancer Center. Journal of the American College of Radiology. 21(9). 1398–1401. 2 indexed citations
6.
Wall, Sarah, Ying Huang, Edmund Folefac, et al.. (2023). Slow and Steady Wins the Race: Optimization of Older Adult Allogeneic Hematopoietic Cell Transplant (Allo-HCT) Candidates. Blood. 142(Supplement 1). 2432–2432.
7.
Sharma, Nidhi, Qiuhong Zhao, Francesca Cottini, et al.. (2023). Survival outcomes following autologous stem cell transplant with melphalan 140mg/m 2 versus 200mg/m 2 preparative regimens in patients with multiple myeloma. Leukemia & lymphoma. 64(7). 1315–1321.
8.
Wall, Sarah, Rebecca L. Olin, Vijaya Raj Bhatt, et al.. (2023). The Transplantation Ecosystem: A New Concept to Improve Access and Outcomes for Older Allogeneic Hematopoietic Cell Transplantation Patients. Transplantation and Cellular Therapy. 29(10). 632.e1–632.e10. 8 indexed citations
9.
Kimmick, Gretchen, Mina S. Sedrak, Grant R. Williams, et al.. (2022). Infrastructure to Support Accrual of Older Adults to National Cancer Institute Clinical Trials. JNCI Monographs. 2022(60). 151–158. 2 indexed citations
10.
Khan, Abdullah, Muhammad Salman Faisal, Qiuhong Zhao, et al.. (2022). Outcomes After Salvage Autologous Hematopoietic Cell Transplant for Patients With Relapsed/Refractory Multiple Myeloma: A Single-Institution Experience. Clinical Lymphoma Myeloma & Leukemia. 23(3). e182–e189. 3 indexed citations
11.
Hao, Qiukui, Farid Foroutan, Mi Ah Han, et al.. (2022). Prognosis of older patients with newly diagnosed AML undergoing antileukemic therapy: A systematic review. PLoS ONE. 17(12). e0278578–e0278578. 6 indexed citations
12.
Wall, Sarah, Ying Huang, Carolyn J. Presley, et al.. (2021). Increasing Number of Geriatric Assessment-Identified Deficits Associated with Non-Receipt of Transplant Among Older Adults. Transplantation and Cellular Therapy. 27(3). S437–S438. 1 indexed citations
13.
Mian, Hira, Shakira J. Grant, Monika Engelhardt, et al.. (2020). Caring for older adults with multiple myeloma during the COVID-19 Pandemic: Perspective from the International Forum for Optimizing Care of Older Adults with Myeloma. Journal of Geriatric Oncology. 11(5). 764–768. 19 indexed citations
14.
Huang, Ying, Nita Williams, Nidhi Sharma, et al.. (2017). Ninety-Minute Daratumumab Infusion Is Safe in Multiple Myeloma. Blood. 130. 1889–1889. 2 indexed citations
15.
Williams, Nita, Nidhi Sharma, Don M. Benson, et al.. (2017). B-Cell Lymphoma Patients Have a 10% Risk of Shingles, 7% in Cutaneous T-Cell Lymphoma. Blood. 130. 3356–3356. 1 indexed citations
16.
Sharma, Nidhi, Nita Williams, Don M. Benson, et al.. (2017). Shingles Occurs in Only 0.5% of Myeloma Patients on Any Dose of Antiviral Prophylaxis. Blood. 130. 4645–4645. 1 indexed citations
17.
Rosko, Ashley & Andrew Artz. (2017). Reprint of: Aging: Treating the Older Patient. Biology of Blood and Marrow Transplantation. 23(3). S10–S17. 2 indexed citations
18.
Harshman, Sean W., Alessandro Canella, Kitty Agarwal, et al.. (2016). Proteomic characterization of circulating extracellular vesicles identifies novel serum myeloma associated markers. Journal of Proteomics. 136. 89–98. 72 indexed citations
19.
Sborov, Douglas W., Gerard J. Nuovo, Andrew Stiff, et al.. (2014). A Phase I Trial of Single-Agent Reolysin in Patients with Relapsed Multiple Myeloma. Clinical Cancer Research. 20(23). 5946–5955. 71 indexed citations
20.
Rosko, Ashley, Nuntra Suwantarat, Lisa M. Arfons, et al.. (2013). Vancomycin-resistant enterococci infection: not just for the transplanted. Leukemia & lymphoma. 55(6). 1320–1325. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Charlotte Bradbury Breakdown of academic impact, for papers by Phillip Parente Breakdown of academic impact, for papers by Phuong Nguyen Breakdown of academic impact, for papers by Camilla Qvortrup Breakdown of academic impact, for papers by Kathleen Donohue Breakdown of academic impact, for papers by Elisabetta Todisco Breakdown of academic impact, for papers by Sandra Kurtin Breakdown of academic impact, for papers by Safi Shahda Breakdown of academic impact, for papers by Xiaobo Zhong Breakdown of academic impact, for papers by Deborah Hurst
Rankless by CCL
2026